List view / Grid view
The multiple serotypes of rhinovirus have presented difficulties for vaccine developers. Now, a team led by Professor Gary McLean from London Metropolitan University and Imperial College London, alongside Professor Sebastian Johnston from Imperial, has formulated a potential vaccine. Nikki Withers spoke to McLean to discover how the vaccine works and…
6 July 2016 | By Victoria White, Digital Content Producer
Sanofi Pasteur has signed a Cooperative Research and Development Agreement with the WRAIR on the co-development of a Zika vaccine candidate...
29 March 2016 | By Victoria White
Using a technique called COBRA, researchers created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza strains...
4 February 2016 | By Victoria White, Digital Content Producer, Drug Target Review
The Zika virus has taken hold in South America. Its possible link to microcephaly in newborn babies and neurological conditions has led the World Health Organization to declare a Public Health Emergency of International Concern. Here we discuss the virus, countermeasures and the race for a vaccine...
14 January 2016 | By Victoria White
The Human Vaccines Project is a research programme designed to accelerate the development of vaccines by decoding the human immune system...
10 November 2015 | By Victoria White
Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
